Connection

Antonio Gasbarrini to Infliximab

Back to Details
This is a "connection" page, showing publications Antonio Gasbarrini has written about Infliximab.
Antonio Gasbarrini
Connection Strength
0.587
Infliximab
  1. Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab. PLoS One. 2017; 12(10):e0186575.
    View in: PubMed
    Score: 0.502
  2. Infliximab in the treatment of steroid-dependent ulcerative colitis. Eur Rev Med Pharmacol Sci. 2004 Sep-Oct; 8(5):231-3.
    View in: PubMed
    Score: 0.050
  3. Anti-tumor necrosis factor a therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis. World J Gastroenterol. 2019 Mar 28; 25(12):1465-1477.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.